Roche's Boniva Patents Are Obvious, Fed. Circ. Affirms
The Federal Circuit on Friday upheld a lower court's decision invalidating two patents owned by Hoffmann-La Roche Inc. for the osteoporosis drug Boniva, ruling that they would be obvious in view...To view the full article, register now.
Already a subscriber? Click here to view full article